As strong growth continues across the global pharmaceuticals industry, the sub-category of temperature-controlled products is surging ahead. Sales volume for these highly sensitive products is growing at twice the rate of the industry overall, with $318 billion in global sales in 2018 accounting for more than one-quarter (27%) of total sales volume.
This exponential growth also brings surging demand for specialized, temperature-controlled logistics services to safely, reliably and cost-effectively distribute high-value, high-sensitivity products. By 2022, 30 of the 50 top global biopharma products will require cold chain handling.
Fueled by this demand, biopharma cold chain logistics grew to $15 billion in 2018. With projected 12.7% YOY growth, analysts predict it will reach nearly $17 billion by 2021.
Read More
